We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+12.41%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$27.2B
AUM Growth
+$1.69B
(+6.6%)
Cap. Flow
-$837M
Cap. Flow
% of AUM
-3.08%
Top 10 Holdings %
Top 10 Hldgs %
35.28%
Holding
550
New
72
Increased
170
Reduced
177
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$151M |
| 2 |
JPMorgan Chase
JPM
|
+$120M |
| 3 |
Qualcomm
QCOM
|
+$115M |
| 4 |
VeriSign
VRSN
|
+$107M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$376M |
| 2 |
Microsoft
MSFT
|
+$285M |
| 3 |
Home Depot
HD
|
+$167M |
| 4 |
Abbott
ABT
|
+$157M |
| 5 |
Sherwin-Williams
SHW
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.58% |
| 2 | Healthcare | 21.35% |
| 3 | Consumer Discretionary | 13.11% |
| 4 | Financials | 10.29% |
| 5 | Communication Services | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
PVH
PVH
$3.87B
| $342K | ﹤0.01% |
3,250
| – | – |
|
|
CBIO
402
Crescent Biopharma
CBIO
$626M
| $317K | ﹤0.01% |
600
| – | – |
|
403
Freshpet
FRPT
$2.92B
| $295K | ﹤0.01% |
5,000
-7,000
| -58% | -$373K |
|
404
Kroger
KR
$35.5B
| $291K | ﹤0.01% |
10,050
| – | – |
|
|
EGOV
405
DELISTED
NIC Inc
EGOV
| $266K | ﹤0.01% |
+11,891
| New | +$260K |
|
|
SGMO
406
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $251K | ﹤0.01% |
+30,000
| New | +$276K |
|
407
Atara Biotherapeutics
ATRA
$69.5M
| $247K | ﹤0.01% |
600
| – | – |
|
|
FPRX
408
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $230K | ﹤0.01% |
+50,000
| New | +$198K |
|
|
PRNB
409
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $219K | ﹤0.01% |
+4,000
| New | +$149K |
|
|
TBIO
410
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $195K | ﹤0.01% |
24,000
+13,000
| +118% | +$120K |
|
411
Helios Technologies
HLIO
$2.59B
| $193K | ﹤0.01% |
4,166
+3,828
| +1,133% | +$164K |
|
412
Stoke Therapeutics
STOK
$1.83B
| $170K | ﹤0.01% |
6,000
-6,000
| -50% | -$151K |
|
413
Skyworks Solutions
SWKS
$9.54B
| $139K | ﹤0.01% |
1,151
| – | – |
|
414
AnaptysBio
ANAB
$1.59B
| $130K | ﹤0.01% |
+8,000
| New | +$189K |
|
|
HZNP
415
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $109K | ﹤0.01% |
+3,000
| New | +$92K |
|
|
CLSD
416
DELISTED
Clearside Biomedical
CLSD
| $87K | ﹤0.01% |
+2,000
| New | +$42K |
|
417
Pool Corp
POOL
$6.73B
| $84K | ﹤0.01% |
397
+71
| +22% | +$14.7K |
|
418
Crown Holdings
CCK
$12.9B
| $83K | ﹤0.01% |
1,147
+669
| +140% | +$47.7K |
|
419
T. Rowe Price
TROW
$25.5B
| $83K | ﹤0.01% |
684
+407
| +147% | +$48.1K |
|
420
WIX.com
WIX
$2.36B
| $78K | ﹤0.01% |
636
-92,179
| -99% | -$11.3M |
|
421
CarMax
KMX
$8.29B
| $77K | ﹤0.01% |
877
+519
| +145% | +$48.8K |
|
422
Corpay
CPAY
$24.8B
| $77K | ﹤0.01% |
269
+56
| +26% | +$16.5K |
|
423
MSCI
MSCI
$41.5B
| $70K | ﹤0.01% |
272
-136
| -33% | -$33.2K |
|
424
NVR
NVR
$16.9B
| $69K | ﹤0.01% |
18
+5
| +38% | +$18.5K |
|
|
ORTX
425
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $69K | ﹤0.01% |
+500
| New | +$60.8K |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q4 2019 Portfolio in Review
As of Q4 2019, Fred Alger Management held 550 positions worth $27.2B, up 6.6% from $25.5B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Fred Alger Management withdrew a net $837M in Q4 2019, closing 71 positions and reducing 177 holdings. Its most notable exit was iRhythm Holdings, an estimated $39.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in CrowdStrike worth $41.4M.
- Fred Alger Management's largest Q4 2019 buy was CrowdStrike: 3,323,112 shares worth $41.4M.
- Fred Alger Management added most to UnitedHealth in Q4 2019, an estimated $151M increase.
- Fred Alger Management's biggest Q4 2019 reduction was Amazon, cutting an estimated $376M.
- Fred Alger Management fully exited iRhythm Holdings in Q4 2019, selling an estimated $39.8M.
- Fred Alger Management's ten largest holdings make up 35% of its $27.2B portfolio in Q4 2019.
- Fred Alger Management opened 72 new positions and closed 71 in Q4 2019.
- Fred Alger Management's portfolio value rose 6.6% quarter-over-quarter to $27.2B.
Based on Fred Alger Management's 13F filing for Q4 2019, filed 14 Feb 2020.